One of the out-patient rehabilitation options for individuals in Roanoke who are struggling with opioid dependence and addiction is called opioid maintenance therapy. Licensed facilities and doctors are authorized to dispense specific meds to opioid dependent people, many of which are opioid-based themselves and are addiction. In low enough amounts the individual doesn't experience being high and also does not have acute cravings and isn't in opioid withdrawal. Methadone is the first medication tried for this purpose, but there are alternative choices to pick from.
Methadone is an opioid and can be taken at an out-patient clinic licensed to dispense the drug, which is taken on a daily basis in liquid or pill form. The price of the med is approximately $150 a month. Buprenorphine is also an opioid based med, and is a pill often taken every other day. But unlike Methadone that can only be administered in well-regulated clinics, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around three hundred dollars monthly for the generic of the drug. There is also a version of buprenorphine containing the drug naloxone, that is a drug which reverses the effects of opioids. Someone consuming this version of the drug, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken daily, and costs approximately $450 /month. Naltrexone is another drug used in opioid maintenance therapy, but unlike the other drugs mentioned here it's an opiate blocker and isn't an opiate. A person has the choice to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents someone from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 monthly.
There are 2 Drug and Alcohol Rehab Facilities offering this service in Roanoke, VA
For All Drug and Alcohol Treatment Facilities In Roanoke, Click Here.